Browsing Tag
SGLT-2 inhibitors
1 post
Lupin acquires diabetes trademarks from Boehringer Ingelheim to bolster treatment portfolio
Lupin Limited, a global pharmaceutical leader based in Mumbai, has announced the acquisition of three anti-diabetes trademarks—GIBTULIO, GIBTULIO…